People on the Move
Convoy Therapeutics
Convoy Therapeutics, which develops new dermatology drugs, has appointed Mary Spellman as its Chief Medical Officer (CMO).
Spellman joins the executive team after ten years in the pharmaceutical industry, including a role as CMO for Revance Therapeutics, and senior positions at Biogen Idec and Novartis.
Convoy’s CEO John Muraski said Spellman “will be instrumental in overseeing all of our planned clinical studies for CycloPsorb and our other programs." CycloPsorb is among the company’s dermatology offerings, and is a topical formulation of cyclosporine for psoriasis and eczema.
